DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 44401 - 44425 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID Gene Name UniProt ID ▲
C0011847 Diabetes MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0015526 Factor XII Deficiency MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0376480 Gingival Overgrowth MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0011860 Diabetes Mellitus, Non-Insulin-Dependent MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0011849 Diabetes Mellitus MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0027819 Neuroblastoma MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0038273 Stereotypic Movement Disorder MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0025958 Microcephaly MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C1306589 Congenital dyserythropoietic anemia, type II MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0272375 Antithrombin III Deficiency MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0013336 Dwarfism MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0700095 Central neuroblastoma MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0221356 Brachycephaly MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C3151409 GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0018818 Ventricular Septal Defects MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0036857 Severe intellectual disability MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0011860 Diabetes Mellitus, Non-Insulin-Dependent GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0006826 Malignant Neoplasms GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0027651 Neoplasms GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C1956346 Coronary Artery Disease GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0028754 Obesity GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0036341 Schizophrenia GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0699791 Stomach Carcinoma GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0020456 Hyperglycemia GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471
C0017638 Glioma GALNT2 2590 polypeptide N-acetylgalactosaminyltransferase 2 Q10471

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024